Biomedicine & Pharmacotherapy · 2017 · 11 citations · 20 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyOncology PharmacotherapyCancer Cell SignalingChemotherapy ResistanceMalignant NeoplasmsPharmacodynamics Of Anticancer AgentsThyroid CancerAnticancer ActivityAnticancer Drug ResistanceAntimetabolite CombinationsCancer Cell Proliferation InhibitionDoxorubicin-based TherapyDrug Resistance ModulationTherapeutic Resistance Mechanisms
20
BRAF mutation predicts sensitivity to MEK inhibition
David B. Solit, Levi A. Garraway, Christine A. Pratilas et al. · Nature · 2005 · 1.3K citations · Full text
FAK integrates growth-factor and integrin signals to promote cell migration
David J. Sieg, Christof R. Hauck, Duško Ilić et al. · Nature Cell Biology · 2000 · 1.2K citations · Full text
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
Judith S. Sebolt–Leopold, David T. Dudley, Román Herrera et al. · Nature Medicine · 1999 · 969 citations
Medicine, Cancer Biology, Oncology +14
Regulation of chemotaxis by the platelet-derived growth factor receptor-β
Vikas Kundra, Jaime A. Escobedo, Andrius Kazlauskas et al. · Nature · 1994 · 439 citations